Effector Therapeutics Inc (EFTR) — Capital Reinvestment Ratio
Effector Therapeutics Inc (EFTR) has a Capital Reinvestment Ratio of 0.01x as of December 2020, meaning it reinvests 0% of its operating cash flow ($13.84 Million) in capital expenditures ($154.00K). See EFTR equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Effector Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Effector Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Effector Therapeutics Inc (EFTR) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Effector Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Effector Therapeutics Inc from 2020 to 2020. For live market cap and broader valuation context, see EFTR market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.01x | $13.84 Million | $154.00K | — |